Trials / Completed
CompletedNCT03982238
Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients
Effects of Continuous Subcutaneous Insulin Infusion and Oral Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Majianhua · Academic / Other
- Sex
- Male
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The study will assess the total testosterone and sex hormone-binding globulin levels in men with type 2 diabetes before and after continuous subcutaneous insulin infusion and hypoglycemic drugs treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Insulin | Continuous subcutaneous insulin infusion therapy for 1 month |
| DRUG | Metformin | Continuous subcutaneous insulin infusion plus metformin (at least1000mg/day) for 1 month |
| DRUG | Dapagliflozin | Continuous subcutaneous insulin infusion plus metformin (10mg/day) for 1 month |
Timeline
- Start date
- 2019-06-15
- Primary completion
- 2019-11-15
- Completion
- 2019-12-31
- First posted
- 2019-06-11
- Last updated
- 2020-04-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03982238. Inclusion in this directory is not an endorsement.